CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850642577
- Phone
- 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- 424B5 Offering Prospectus
- 8-K Event Results of operations
- 424B5 Offering Prospectus
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Executive or director change · Regulation FD disclosure · Other events
- S-3 Offering Registration Statement
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award Chief Medical Officer acquired 34,000 shares (grant or award)
- 4 Grant or award SVP, Finance and CAO acquired 26,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 32,000 shares (grant or award)
- 4 Grant or award President & CEO acquired 89,000 shares (grant or award)
- 4 Open-market sale VP, Finance and CAO sold 7,345 shares at $6.52 ($47,889)
- 4 Open-market sale Chief Medical Officer sold 1,605 shares at $7.34 ($11,781)
Page 11 of 22 · 421 filings